Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blind cane study reveals how tools become part of the body

NCT ID NCT05199896

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how blind people use a white cane to sense the world around them, not just to move. Researchers will test how well users can feel where a touch happens on the cane and measure brain activity during these tasks. The goal is to understand how the cane becomes an extension of the body. The study involves 300 adults, both blind and sighted, and includes EEG and brain scans.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2022

Expected to finish

Oct 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Man or woman, aged 18 to 60 years old * Give an informed consent by signature * Be part of the national health security system (registered to the Securité Sociale) * do not confuse his right and his left Specific of the non-sighted participants: * Loss of vision happened at birth or 3-to 5 years later minimum in life * Must have a visual acuity inferior or equal to 4/10 * Be with a close relation for read information letter and sign the consent form if needed Exclusion Criteria: * A person presenting an history of neurological, psychiatric or linguistic problems cannot be admitted * Assumption of psychotropic drugs * Pregnancy or breast-feeding woman * A person under legal tutoring * A person under care in other medical structure for reasons different from those of this research * A person under administrative or judiciary contention * A person who is not eligible to a MRI-exam according to the following criteria cannot be admitted to the experiments including MR acquisitions : * Have a neurological, cardiac (battery) or defibrillator pacemaker * Have a cardiac prosthesis (valve, stent...) or vascular prosthesis * Have intracranial clips or clamps * Carry a bypass of the cerebrospinal fluid * Having metallic splinters in the eyes * Wear metal prostheses (teeth, knees) * Wear an infusion pump or system * Be claustrophobic or have respiratory problems * Have metal tattoos close to the head * Have permanent make-up

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blindness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Equipe IMPACT du CRNL, Bâtiment INSERM

    RECRUITING

    Bron, 69676, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.